CEDRA treats patients affected with different types of dementia, predominantly Alzheimer’s disease.

500 000 people are affected by Alzheimer's disease in Canada.  With the population aging, the incidence and prevalence of dementia, particularly Alzheimer's disease, will increase significantly in the coming years.

CEDRA concentrates its efforts on early diagnosis and prevention. We are involved in research to discover more effective treatments and allow patients to preserve their cognitive capacities and their health.

CEDRA is dedicated to meet the needs of patients affected by Alzheimer’s disease and support their families.

From all the team members